Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Hoffmann

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Chinese Clinical Oncology|April 6, 2015
Integrative oncology drug discovery accompanied by preclinical translational research as prerequisite for clinical developmentJens Hoffmann
Frontiers in Oncology|October 20, 2018
Editorial: Cancer ModelsMichael Breitenbach, Jens Hoffmann
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|May 25, 2016
[School shootings by adult outsiders – psychiatric aspects and risk markers]Jens Hoffmann, Mirko Allwinn
Cancer Treatment Reviews|March 18, 2017
Choosing wisely - Preclinical test models in the era of precision medicineKonrad Klinghammer, Wolfgang Walther, Jens Hoffmann
Expert Opinion on Investigational Drugs|October 17, 2008
Sagopilone (ZK-EPO): from a natural product to a fully synthetic clinical development candidateUlrich Klar, Jens Hoffmann, Marius Giurescu
Handbook of Experimental Pharmacology|October 23, 2015
Predictive In Vivo Models for OncologyDiana Behrens, Jana Rolff, Jens Hoffmann
Magma (New York, N.Y.)|November 27, 2013
Numerical and experimental evaluation of RF shimming in the human brain at 9.4 T using a dual-row transmit arrayJens Hoffmann, Gunamony Shajan, Klaus Scheffler, et al.
Behavioral Sciences & the Law|March 8, 2011
Attacks on German public figures, 1968-2004: warning behaviors, potentially lethal and non-lethal acts, psychiatric status, and motivationsJens Hoffmann, J Reid Meloy, Angela Guldimann, et al.
Behavioral Sciences & the Law|May 5, 2012
The role of warning behaviors in threat assessment: an exploration and suggested typologyJ Reid Meloy, Jens Hoffmann, Angela Guldimann, et al.
Expert Opinion on Investigational Drugs|March 28, 2008
Investigational developments for the treatment of progesterone-dependent diseasesCarsten Möller, Jens Hoffmann, Thomas A Kirkland, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Chinese Clinical Oncology|April 6, 2015
Integrative oncology drug discovery accompanied by preclinical translational research as prerequisite for clinical developmentJens Hoffmann
Frontiers in Oncology|October 20, 2018
Editorial: Cancer ModelsMichael Breitenbach, Jens Hoffmann
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|May 25, 2016
[School shootings by adult outsiders – psychiatric aspects and risk markers]Jens Hoffmann, Mirko Allwinn
Cancer Treatment Reviews|March 18, 2017
Choosing wisely - Preclinical test models in the era of precision medicineKonrad Klinghammer, Wolfgang Walther, Jens Hoffmann
Expert Opinion on Investigational Drugs|October 17, 2008
Sagopilone (ZK-EPO): from a natural product to a fully synthetic clinical development candidateUlrich Klar, Jens Hoffmann, Marius Giurescu
Handbook of Experimental Pharmacology|October 23, 2015
Predictive In Vivo Models for OncologyDiana Behrens, Jana Rolff, Jens Hoffmann
Magma (New York, N.Y.)|November 27, 2013
Numerical and experimental evaluation of RF shimming in the human brain at 9.4 T using a dual-row transmit arrayJens Hoffmann, Gunamony Shajan, Klaus Scheffler, et al.
Behavioral Sciences & the Law|March 8, 2011
Attacks on German public figures, 1968-2004: warning behaviors, potentially lethal and non-lethal acts, psychiatric status, and motivationsJens Hoffmann, J Reid Meloy, Angela Guldimann, et al.
Behavioral Sciences & the Law|May 5, 2012
The role of warning behaviors in threat assessment: an exploration and suggested typologyJ Reid Meloy, Jens Hoffmann, Angela Guldimann, et al.
Expert Opinion on Investigational Drugs|March 28, 2008
Investigational developments for the treatment of progesterone-dependent diseasesCarsten Möller, Jens Hoffmann, Thomas A Kirkland, et al.
Pageof 9